Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 12Breast Neoplasms 9Neoplasms 6Leukemia, Myeloid, Acute 3Prostatic Neoplasms 2Patient Compliance 2Neoplasm Metastasis 2Fatigue 2Depression 2Colorectal Neoplasms 2Brain Neoplasms 2Weight Loss 1Weight Gain 1Smoking Cessation 1Peripheral Nervous System Diseases 1Overweight 1Ovarian Neoplasms 1Obesity 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Lung Neoplasms 1Insulin Resistance 1Infratentorial Neoplasms 1Fallopian Tube Neoplasms 1Disease 1Cognitive Dysfunction 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Bone Metabolism Biomarkers 1Body Weight Changes 1

Interventions

Glutamine 2sagopilone 1nicotinamide-beta-riboside 1allantoicase 1Vitamin D 1Vitamin B 6 1Vitamin B 12 1Taxoids 1Tadalafil 1Sirolimus 1Prednisolone 1Paclitaxel 1Minocycline 1Metformin 1Losartan 1Hydroxychloroquine 1G(M1) Ganglioside 1Fatty Acids, Omega-3 1Exercise 1Everolimus 1Etoricoxib 1Ethosuximide 1Epoetin Alfa 1Dietary Supplements 1Dexamethasone 1Cryotherapy 1Bortezomib 1BID protein, human 1Acupuncture Therapy 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Peripheral Nervous System Diseases × Exercise × Clear all
NCT05488873 2024-07-22

A Study of Topical Pirenzepine or Placebo in Oncology Patients With Chemotherapy Induced Peripheral Neuropathy

WinSanTor, Inc

Phase 2 Active not recruiting
60 enrolled

Neoplasms, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡